2014 Q3 Form 10-K Financial Statement

#000114420414058370 Filed on September 29, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2014
Revenue $3.160M $3.210M $9.709M
YoY Change 128.03% 52.13% 7.93%
Cost Of Revenue $2.210M $2.280M $7.315M
YoY Change 66.58% 15.15% -5.39%
Gross Profit $950.0K $920.0K $2.394M
YoY Change 1507.55% 607.69% 89.49%
Gross Profit Margin 30.06% 28.66% 24.66%
Selling, General & Admin $460.0K $380.0K $1.970M
YoY Change 13.0% 15.15% 4.39%
% of Gross Profit 48.42% 41.3% 82.31%
Research & Development $0.00 $156.7K
YoY Change -100.0% -64.77%
% of Gross Profit 0.0% 6.55%
Depreciation & Amortization $240.0K $450.0K $1.136M
YoY Change 13.32% 650.0% 175.73%
% of Gross Profit 25.26% 48.91% 47.46%
Operating Expenses $660.0K $780.0K $3.114M
YoY Change -13.58% 77.27% 19.23%
Operating Profit $290.0K $140.0K -$720.1K
YoY Change -141.16% -145.16% -46.59%
Interest Expense -$10.00K $0.00 $111.8K
YoY Change -150.0% -100.0% -8.17%
% of Operating Profit -3.45% 0.0%
Other Income/Expense, Net $40.00K $70.00K $61.61K
YoY Change -18.49% -50.97%
Pretax Income $330.0K $210.0K -$658.5K
YoY Change -150.34% -177.78% -46.15%
Income Tax $100.0K $0.00 $0.00
% Of Pretax Income 30.3% 0.0%
Net Earnings $220.0K $210.0K -$658.5K
YoY Change -133.56% -177.78% -47.18%
Net Earnings / Revenue 6.96% 6.54% -6.78%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $3.535K $3.374K -$0.01
COMMON SHARES
Basic Shares Outstanding 62.24M shares 62.24M shares 62.24M shares
Diluted Shares Outstanding 62.24M shares

Balance Sheet

Concept 2014 Q3 2014 Q2 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.03M $27.23M $27.23M
YoY Change -2.03% -5.68% -5.58%
Cash & Equivalents $28.03M $27.23M $27.23M
Short-Term Investments
Other Short-Term Assets $160.0K $140.0K $140.0K
YoY Change 128.57% -57.58% -39.13%
Inventory $1.010M $1.040M $1.040M
Prepaid Expenses $102.0K
Receivables $2.240M $2.230M $2.230M
Other Receivables $110.0K $110.0K $110.0K
Total Short-Term Assets $31.56M $30.75M $30.75M
YoY Change -30.15% 0.88% -32.49%
LONG-TERM ASSETS
Property, Plant & Equipment $5.120M $4.661M $4.660M
YoY Change 58.56% 82.0% 42.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.48M $10.12M $10.12M
YoY Change 20.39% -9.83% 13.84%
TOTAL ASSETS
Total Short-Term Assets $31.56M $30.75M $30.75M
Total Long-Term Assets $10.48M $10.12M $10.12M
Total Assets $42.04M $40.87M $40.87M
YoY Change -21.99% -2.0% -24.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $640.0K $630.0K $630.0K
YoY Change 611.11% 16.67% 425.0%
Accrued Expenses $70.00K $70.00K $70.00K
YoY Change -53.33% -63.16% -68.18%
Deferred Revenue
YoY Change
Short-Term Debt $3.860M $1.612M $3.390M
YoY Change 797.67% 41.33% 688.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.370M $4.820M $4.820M
YoY Change 467.96% 4.78% 386.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.370M $4.820M $4.820M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.370M $4.820M $4.820M
YoY Change 465.26% 4.78% 386.87%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.67M $36.05M $36.05M
YoY Change
Total Liabilities & Shareholders Equity $42.04M $40.87M $40.87M
YoY Change -21.99% -2.0% -24.93%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2014
OPERATING ACTIVITIES
Net Income $220.0K $210.0K -$658.5K
YoY Change -133.56% -177.78% -47.18%
Depreciation, Depletion And Amortization $240.0K $450.0K $1.136M
YoY Change 13.32% 650.0% 175.73%
Cash From Operating Activities $560.0K $320.0K -$1.353M
YoY Change -281.08% -277.78% -126.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K $126.0K
YoY Change -100.0% -98.0% 128.56%
Acquisitions
YoY Change
Other Investing Activities $10.00K $10.00K $10.00K
YoY Change
Cash From Investing Activities $0.00 -$20.00K -$131.4K
YoY Change -100.0% -98.67% -97.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K -170.0K $141.9K
YoY Change -180.95% -66.35%
NET CHANGE
Cash From Operating Activities 560.0K 320.0K -$1.353M
Cash From Investing Activities 0.000 -20.00K -$131.4K
Cash From Financing Activities -50.00K -170.0K $141.9K
Net Change In Cash 510.0K 130.0K -$1.343M
YoY Change -264.92% -108.84% 49.73%
FREE CASH FLOW
Cash From Operating Activities $560.0K $320.0K -$1.353M
Capital Expenditures $0.00 -$30.00K $126.0K
Free Cash Flow $560.0K $350.0K -$1.479M
YoY Change -293.6% -73.48% -128.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
1140548 USD
CY2014Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
1611967 USD
CY2013Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
542699 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
627109 USD
CY2013Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
200761 USD
CY2014Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
245308 USD
CY2013Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
171598 USD
CY2014Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
40504 USD
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
156750 USD
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
101965 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7315171 USD
CY2013 us-gaap Gross Profit
GrossProfit
1263370 USD
CY2014 us-gaap Gross Profit
GrossProfit
2393928 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1887537 USD
CY2013Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2138454 USD
CY2013Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
185096 USD
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
255588 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4600001 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
6224 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27317 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3636312 USD
CY2013Q2 chhe Statutory Reserve
StatutoryReserve
38679 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33394548 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
316 USD
CY2014Q2 us-gaap Minority Interest
MinorityInterest
253 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37103396 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36051513 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40870060 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>Use of Estimates and Assumptions</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. Significant estimates and assumptions by management include, among others; useful lives of long-lived assets and intangible assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, construction in progress, intangible assets and deferred taxes. While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 chhe Sales Tax Description
SalesTaxDescription
Pursuant to the tax law and regulations of the PRC, the Company is obligated to pay 7% and 5% of the annual VAT paid as taxes on maintaining and building cities and education additional fees, both of which belong to sales-related taxes.
CY2013 chhe Sales Taxes And Sales Related Taxes
SalesTaxesAndSalesRelatedTaxes
150171 USD
CY2014 chhe Sales Taxes And Sales Related Taxes
SalesTaxesAndSalesRelatedTaxes
170599 USD
CY2013Q2 chhe Advance To Suppliers
AdvanceToSuppliers
171598 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1970482 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
279330 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
986847 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
444945 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156735 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
2611812 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
3114064 USD
CY2014Q2 chhe Advance To Suppliers
AdvanceToSuppliers
40504 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
9979 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45463 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
430282 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
524446 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
230897 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
248304 USD
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>Concentrations of Business and Credit Risks</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">All of the Company&#8217;s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company&#8217;s financial position, results of operations and cash flows. Also, the success of the Company&#8217;s operations is subject to numerous contingencies, some of which are beyond management&#8217;s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company&#8217;s operations will be subject to the risks of restrictions on transfer of funds, domestic customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between U.S. dollars and the Chinese currency RMB. The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting periods.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
343463 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62239737 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62239737 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62239737 shares
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
254704 USD
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62239737 shares
CY2013Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
28868533 USD
CY2014Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
27232074 USD
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25 pure
CY2014 chhe Value Added Tax Goods Percentage
ValueAddedTaxGoodsPercentage
13% or 17%
CY2014 chhe Value Added Tax Services Percentage
ValueAddedTaxServicesPercentage
0.17 pure
CY2013 chhe Value Added Tax Amount
ValueAddedTaxAmount
223495 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1279635 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1581371 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2561067 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4661072 USD
CY2013 us-gaap Depreciation
Depreciation
244066 USD
CY2014 us-gaap Depreciation
Depreciation
318761 USD
CY2013 chhe Depreciation Expense Charged To Operations
DepreciationExpenseChargedToOperations
111385 USD
CY2014 chhe Value Added Tax Amount
ValueAddedTaxAmount
287441 USD
CY2014 chhe Depreciation Expense Charged To Operations
DepreciationExpenseChargedToOperations
169565 USD
CY2013 us-gaap Cost Of Goods Sold Depreciation
CostOfGoodsSoldDepreciation
132681 USD
CY2014 us-gaap Cost Of Goods Sold Depreciation
CostOfGoodsSoldDepreciation
149196 USD
CY2014 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2437639 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8995653 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9709099 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7732283 USD
CY2013 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1348442 USD
CY2014 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-720136 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
247642 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
111810 USD
CY2013 us-gaap Interest Expense
InterestExpense
121703 USD
CY2014 us-gaap Interest Expense
InterestExpense
111758 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-281 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61557 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
125658 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
61609 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1222784 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-658527 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Profit Loss
ProfitLoss
-1246716 USD
CY2014 us-gaap Profit Loss
ProfitLoss
-658527 USD
CY2013 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-188 USD
CY2014 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-60 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-1246528 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-658467 USD
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-393356 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
47737 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1051883 USD
CY2013 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-174 USD
CY2014 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-63 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47911 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1051820 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
444742 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1248634 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6316925 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5452161 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167945 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817281 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23932 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
148498 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
301764 USD
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148498 USD
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
313130 USD
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2014 chhe Deferred Tax Asset Reduce Percentage
DeferredTaxAssetReducePercentage
0 pure
CY2014 chhe Enterprise Income Tax Rate
EnterpriseIncomeTaxRate
0.25 pure
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
15337 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
412011 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1136042 USD
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35971 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2191291 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2154160 USD
CY2013 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-99 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-23555 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-152539 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44487 USD
CY2013 chhe Increase Decrease In Advances To Suppliers
IncreaseDecreaseInAdvancesToSuppliers
-3845922 USD
CY2014 chhe Increase Decrease In Advances To Suppliers
IncreaseDecreaseInAdvancesToSuppliers
-184324 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
65325 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
91141 USD
CY2013 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-57342 USD
CY2014 us-gaap Increase Decrease In Customer Advances And Deposits
IncreaseDecreaseInCustomerAdvancesAndDeposits
-4959 USD
CY2013 chhe Increase Decrease In Wages Payables
IncreaseDecreaseInWagesPayables
46177 USD
CY2014 chhe Increase Decrease In Wages Payables
IncreaseDecreaseInWagesPayables
-114790 USD
CY2013 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-232480 USD
CY2014 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
152725 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5176826 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1353165 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55123 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125991 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4805401 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11404 USD
CY2013 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
1634745 USD
CY2014 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
0 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6495269 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131380 USD
CY2013 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
4326 USD
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
376175 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1064595 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29339 USD
CY2013 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
638510 USD
CY2014 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2013 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
CY2014 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
488759 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
421759 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
141923 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
995059 USD
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-293837 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
98375 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1636459 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28770157 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
23932 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
48361 USD
CY2013 us-gaap Interest Paid
InterestPaid
121703 USD
CY2014 us-gaap Interest Paid
InterestPaid
117623 USD
CY2013 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
0 USD
CY2014 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2342845 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
China Health Industries Holdings, Inc.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001309057
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q4 dei Entity Public Float
EntityPublicFloat
26839529 USD
CY2014 dei Trading Symbol
TradingSymbol
CHHE
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62239737 shares
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1246528 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-658527 USD
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62239737 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62239737 shares
CY2013 us-gaap Dilutive Securities
DilutiveSecurities
USD
CY2014 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62239737 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62239737 shares
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
0 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
11366 USD
CY2013Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
0 USD
CY2014Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
10485 USD
CY2013Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
136855 USD
CY2014Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
83798 USD
CY2013 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
0 USD
CY2014 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
-6015 USD
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37055658 USD
CY2013 chhe Total Payment To Contractor
TotalPaymentToContractor
9000000 CNY
CY2013 chhe Total Payment To Contractor
TotalPaymentToContractor
1466419 USD
CY2014 chhe Total Payment To Contractor
TotalPaymentToContractor
9000000 CNY
CY2014Q2 us-gaap Prepaid Taxes
PrepaidTaxes
48878 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
37103080 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
36051260 USD

Files In Submission

Name View Source Status
0001144204-14-058370-index-headers.html Edgar Link pending
0001144204-14-058370-index.html Edgar Link pending
0001144204-14-058370.txt Edgar Link pending
0001144204-14-058370-xbrl.zip Edgar Link pending
chhe-20140630.xml Edgar Link completed
chhe-20140630.xsd Edgar Link pending
chhe-20140630_cal.xml Edgar Link unprocessable
chhe-20140630_def.xml Edgar Link unprocessable
chhe-20140630_lab.xml Edgar Link unprocessable
chhe-20140630_pre.xml Edgar Link unprocessable
ex4-1pg01.jpg Edgar Link pending
ex4-1pg02.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kccwlogo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg4n7.jpg Edgar Link pending
v389876_10k.htm Edgar Link pending
v389876_ex10-10.htm Edgar Link pending
v389876_ex21-1.htm Edgar Link pending
v389876_ex31-1.htm Edgar Link pending
v389876_ex31-2.htm Edgar Link pending
v389876_ex32-1.htm Edgar Link pending
v389876_ex4-1.htm Edgar Link pending